Mantra Pharma
Mantra Pharma Inc. is a publicly reporting company focused on acquiring and developing advanced pharmaceutical and medical projects globally, with an emphasis on artificial intelligence (AI) to enhance value-driven assets. The company seeks to build shareholder value by collaborating with innovators, research institutions, and small businesses to bring innovative biopharma products to market. Having terminated its previous medical marijuana project in Croatia due to regulatory delays, Mantra Pharma is actively reviewing new pharmaceutical and medical projects for acquisition, targeting the growing global elderly population and favorable market conditions. The company operates under high business standards and ethics, led by an experienced team, and is pursuing a stock exchange listing in Canada.
Mantra Pharma
Mantra Pharma Inc. is a publicly reporting company focused on acquiring and developing advanced pharmaceutical and medical projects globally, with an emphasis on artificial intelligence (AI) to enhance value-driven assets. The company seeks to build shareholder value by collaborating with innovators, research institutions, and small businesses to bring innovative biopharma products to market. Having terminated its previous medical marijuana project in Croatia due to regulatory delays, Mantra Pharma is actively reviewing new pharmaceutical and medical projects for acquisition, targeting the growing global elderly population and favorable market conditions. The company operates under high business standards and ethics, led by an experienced team, and is pursuing a stock exchange listing in Canada.